We are live on ! Find out more
QOP

Quinn Opportunity Partners Portfolio holdings

AUM $1.92B
1-Year Est. Return 31.26%
This Fund
S&P 500
This Quarter Est. Return
+5.31%
1 Year Est. Return
+31.26%
3 Year Est. Return
+67.23%
5 Year Est. Return
+49.99%
10 Year Est. Return
+245.23%
AUM
$2.37B
AUM Growth
+$959M
Cap. Flow
+$955M
Cap. Flow %
40.29%
Top 10 Hldgs %
35.28%
Holding
421
New
90
Increased
94
Reduced
62
Closed
52

Top Buys

Rank Stock Value
1
EA
Electronic Arts
EA
+$152M
2
NFLX icon
Netflix
NFLX
+$69.4M
3
HOLX
Hologic
HOLX
+$50.7M
4
EXAS
Exact Sciences
EXAS
+$48.7M
5
JHG
Janus Henderson
JHG
+$43.6M

Top Sells

Rank Stock Value
1
PGRE
Paramount Group
PGRE
+$16M
2
CYTK icon
Cytokinetics
CYTK
+$14.7M
3
ECHO
EchoStar
ECHO
+$13.2M
4
FICO icon
Fair Isaac
FICO
+$12.4M
5
VKTX icon
Viking Therapeutics
VKTX
+$10.6M

Sector Composition

Rank Sector Weight
1 Communication Services 31.86%
2 Consumer Discretionary 15.78%
3 Healthcare 11.2%
4 Technology 10.25%
5 Consumer Staples 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PBPB
401
DELISTED
Potbelly
PBPB
– –
-20,000
Closed -$341K
PGRE
402
DELISTED
Paramount Group
PGRE
– –
-2,447,400
Closed -$16M
PRTS icon
403
CarParts.com
PRTS
$54.3M
– –
-2,044
Closed -$14.5K
RLAY icon
404
Relay Therapeutics
RLAY
$4.36B
– –
-30,000
Closed -$157K
RMR icon
405
The RMR Group
RMR
$329M
– –
-14,314
Closed -$225K
ECHO
406
EchoStar
ECHO
$26.4B
– –
-173,197
Closed -$13.2M
SCOR icon
407
Comscore
SCOR
$109M
– –
-15,216
Closed -$133K
SGRP
408
DELISTED
SPAR Group
SGRP
– –
-10,000
Closed -$10.3K
TDOC icon
409
Teladoc Health
TDOC
$1.29B
– –
-327,551
Closed -$2.53M
TLRY icon
410
Tilray
TLRY
$613M
– –
-139,808
Closed -$2.42M
TLT icon
411
CALL
iShares 20+ Year Treasury Bond ETF
TLT
$40.7B
– –
-188,700
Closed -$16.9M
TMO icon
412
Thermo Fisher Scientific
TMO
$219B
– –
-3,000
Closed -$1.46M
TRNR icon
413
Interactive Strength
TRNR
$1.77M
– –
-215
Closed -$50K
VKTX icon
414
Viking Therapeutics
VKTX
$3.99B
– –
-403,445
Closed -$10.6M
VRA icon
415
Vera Bradley
VRA
$98.4M
– –
-1,022,911
Closed -$2.06M
VSTS icon
416
Vestis
VSTS
$1.87B
– –
-52,000
Closed -$236K
VXX icon
417
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$146M
– –
-67,000
Closed -$2.22M
XELB icon
418
Xcel Brands
XELB
$6.66M
– –
-10,000
Closed -$17.6K
ZIM icon
419
ZIM Integrated Shipping Services
ZIM
$3.14B
– –
-386,529
Closed -$5.24M
LAR
420
Lithium Argentina AG
LAR
$1.17B
– –
-23,855
Closed -$79.7K
MTSR
421
DELISTED
Metsera Inc
MTSR
– –
-17,951
Closed -$939K
13 14 15 16
17

Similar funds

RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
HC
Hamilton Capital Columbus, Ohio $1.93B AUM
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return

Quinn Opportunity Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Quinn Opportunity Partners held 421 positions worth $2.37B, up 68% from $1.41B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Quinn Opportunity Partners deployed $955M of net new capital in Q4 2025, opening 90 new positions and adding to 94 existing holdings. Its largest new stake was Hologic: 693,600 shares worth $51.7M.

By sector, the portfolio is most concentrated in Communication Services at 32% of assets, down from 32% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Cytokinetics, an estimated $14.7M trimmed.

  • Quinn Opportunity Partners's largest Q4 2025 buy was Hologic: 693,600 shares worth $51.7M.
  • Quinn Opportunity Partners added most to Electronic Arts in Q4 2025, an estimated $152M increase.
  • Quinn Opportunity Partners's biggest Q4 2025 reduction was Cytokinetics, cutting an estimated $14.7M.
  • Quinn Opportunity Partners fully exited Paramount Group in Q4 2025, selling an estimated $16M.
  • Quinn Opportunity Partners's ten largest holdings make up 35% of its $2.37B portfolio in Q4 2025.
  • Quinn Opportunity Partners opened 90 new positions and closed 52 in Q4 2025.
  • Quinn Opportunity Partners's portfolio value rose 68% quarter-over-quarter to $2.37B.

Based on Quinn Opportunity Partners's 13F filing for Q4 2025, filed 13 Feb 2026.